Analyst Scoreboard: 4 Ratings For Cerence
Portfolio Pulse from Benzinga Insights
Cerence (NASDAQ:CRNC) has received mixed analyst ratings over the past three months, with a total of 4 ratings including 1 bullish and 3 indifferent. The average 12-month price target for Cerence is now $20.25, marking a 12.5% increase from the previous target of $18. Analyst actions include adjustments to ratings and price targets, reflecting dynamic market conditions and Cerence's performance. Cerence's financials show strong revenue growth, net margin, ROE, and ROA, with a conservative debt management approach.
April 17, 2024 | 12:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cerence has received mixed reviews from analysts, with an updated average 12-month price target of $20.25. The company's strong financial performance, including significant revenue growth and profitability, positions it positively in the market.
The mixed analyst ratings with a higher average price target suggest a cautiously optimistic outlook for Cerence. The company's strong financial indicators, such as revenue growth and net margin, support a positive short-term impact on its stock price. The increase in the average price target reflects analysts' recognition of Cerence's solid performance and market position.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100